This page in English
Laddar profil information


A core outcome set for aphasia treatment research: The ROMA consensus statement
Wallace Sj, Worrall L, Rose T, Le Dorze G, Breitenstein C, Hilari K, et al
International journal of stroke : official journal of the International Stroke Society 2019;14(2):180-185

Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): study protocol for a randomised, stepped-wedge cluster trial within the EFFECTS trial
Lundström E, Isaksson E, Wester P, Laska Ac, Näsman P
Trials 2018;19(1):14-

Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial
Woodhouse Lj, Scutt P, Hamdy S, Smithard Dg, Cohen Dl, Roffe C, et al
Translational stroke research 2018;9(2):120-129

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial
Tich-2 Investigators, Sprigg N, Flaherty K, Appleton Jp, Al-shahi Salman R, Bereczki D, et al
Lancet (London, England) 2018;391(10135):2107-2115

[Encefalopathy as a side effect of metronidazole therapy – a case report]
Karayianni M, Von Heijne A, Laska Ac
Lakartidningen 2017;114():-

Infections Up to 76 Days After Stroke Increase Disability and Death
Enos Trial Investigators, Learoyd Ae, Woodhouse L, Shaw L, Sprigg N, Bereczki D, et al
Translational stroke research 2017;8(6):541-548

Patients with aphasia and an infarct in Wernicke's area benefit from early intensive speech and language therapy
Dembrower Keh, Von Heijne A, Laska Ac, Laurencikas E
APHASIOLOGY 2017;31(1):122-128

Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
Wahlgren N, Thorén M, Höjeberg B, Käll Tb, Laska Ac, Sjöstrand C, et al
Journal of internal medicine 2017;281(3):273-283

Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma
Thålin C, Daleskog M, Göransson Sp, Schatzberg D, Lasselin J, Laska Ac, et al
Immunologic research 2017;65(3):706-712

Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial
Tich-2 Investigators, Sprigg N, Robson K, Bath P, Dineen R, Roberts I, et al
International journal of stroke : official journal of the International Stroke Society 2016;11(6):683-94

NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation
Thålin C, Demers M, Blomgren B, Wong Sl, Von Arbin M, Von Heijne A, et al
Thrombosis research 2016;139():56-64

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
Socrates Steering Committee And Investigators, Johnston Sc, Amarenco P, Albers Gw, Denison H, Easton Jd, et al
The New England journal of medicine 2016;375(1):35-43

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
Xantus Investigators, Camm Aj, Amarenco P, Haas S, Hess S, Kirchhof P, et al
European heart journal 2016;37(14):1145-53

Clopidogrel Resistance after Minor Ischemic Stroke or Transient Ischemic Attack is Associated with Radiological Cerebral Small-Vessel Disease
Lundström A, Wallén H, Von Arbin M, Jörneskog G, Gigante B, Höeg Dembrower K, et al
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2015;24(10):2348-57

Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial
Enos Trial Investigators, Bath Pmw, Woodhouse L, Scutt P, Krishnan K, Wardlaw Jm, et al
LANCET 2015;385(9968):617-628

Elevated Troponin Levels in Acute Stroke Patients Predict Long-term Mortality
Thålin C, Rudberg As, Johansson F, Jonsson F, Laska Ac, Nygren At, et al
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2015;24(10):2390-6

Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial
Enos Investigators, Bath Pmw, Adami A, Bereczki D, Berge E, Beridze M, et al

Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA
Lundström A, Laska Ac, Von Arbin M, Jörneskog G, Wallén H
Platelets 2014;25(2):102-10

International comparisons of acute myocardial infarction
Ejerhed J, Nordenstedt H, Laska Ac
Lancet (London, England) 2014;384(9940):303-4

Time for a step change? Improving the efficiency, relevance, reliability, validity and transparency of aphasia rehabilitation research through core outcome measures, a common data set and improved reporting criteria
Collaboration Aphasia Trialists, Brady Mc, Ali M, Fyndanis C, Kambanaros M, Grohmann Kk, et al
APHASIOLOGY 2014;28(11):1385-1392

Trousseau's Syndrome, a Previously Unrecognized Condition in Acute Ischemic Stroke Associated With Myocardial Injury
Thalin C, Blomgren B, Mobarrez F, Lundstrom A, Laska Ac, Von Arbin M, et al
Journal of investigative medicine high impact case reports 2014;2(2):2324709614539283-

How well do standard stroke outcome measures reflect quality of life? A retrospective analysis of clinical trial data
Vista Collaboration, Ali M, Fulton R, Quinn T, Brady M
Stroke 2013;44(11):3161-5

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Magellan Investigators, Cohen At, Spiro Te, Buller Hr, Haskell L, Hu Dy, et al

Gender differences in quality of life after stroke and TIA: a cross-sectional survey of out-patients
Franzén-dahlin Å, Laska Ac
Journal of clinical nursing 2012;21(15-16):2386-91

A randomized controlled trial on very early speech and language therapy in acute stroke patients with aphasia
Laska Ac, Kahan T, Hellblom A, Murray V, Von Arbin M
Cerebrovascular diseases extra 2011;1(1):66-74

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Perform Study Investigators, Bousser Mg, Amarenco P, Chamorro A, Fisher M, Ford I, et al
LANCET 2011;377(9782):2013-22

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Scast Study Group, Sandset Ec, Bath Pm, Boysen G, Jatuzis D, Kõrv J, et al
Lancet (London, England) 2011;377(9767):741-50

Discarding Heparins as Treatment for Progressive Stroke in Sweden 2001 to 2008
Riks-stroke Collaboration, Eriksson M, Stecksen A, Glader El, Norrving B, Appelros P, et al
STROKE 2010;41(11):2552-8

Quality of life in chronic disease: a comparison between patients with heart failure and patients with aphasia after stroke
Franzen-dahlin A, Karlsson Mr, Mejhert M, Laska Ac
JOURNAL OF CLINICAL NURSING 2010;19(13-14):1855-60

Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
Sparcl Investigators, Chaturvedi S, Zivin J, Breazna A, Amarenco P, Callahan A, et al
Neurology 2009;72(8):688-94

Patient Dissatisfaction With Acute Stroke Care
Riks-stroke Collaboration, Asplund K, Jonsson F, Eriksson M, Stegmayr B, Appelros P, et al
STROKE 2009;40(12):3851-6

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study
Perform Study Investigators, Bousser Mg, Amarenco P, Chamorro A, Fisher M, Ford I, et al
Cerebrovascular diseases (Basel, Switzerland) 2009;27(5):509-18

Design and methods of a randomized controlled trial on early speech and language therapy in patients with acute stroke and aphasia
Laska Ac, Kahan T, Hellblom A, Murray V, Von Arbin M

Predictors of life situation among significant others of depressed or aphasic stroke patients
Franzen-dahlin A, Laska Ac, Larson J, Wredling R, Billing E, Murray V

Relative effects of statin therapy on stroke and cardiovascular events in men and women - Secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study
Sparcl Investigators, Goldstein Lb, Amarenco P, Lamonte M, Gilbert S, Messig M, et al
STROKE 2008;39(9):2444-8

Clinical and prognostic properties of standardized and functional aphasia assessments
Laska Ac, Bartfai A, Hellblom A, Murray V, Kahan T

Recognition of depression in aphasic stroke patients
Laska Ac, Martensson B, Kahan T, Von Arbin M, Murray V

Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: A randomised, double-blind, placebo-controlled study
Laska Ac, Von Arbin M, Kahan T, Hellblom A, Murray V

Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003)
Sparcl Investigators, Clark Wm, Davalos A, Goldstein Lb, Kaste M, Leiter L, et al

Aphasia in acute stroke and relation to outcome
Laska Ac, Hellblom A, Murray V, Kahan T, Von Arbin M

Visa alla publikationer